Concepedia

Sandra Henein

SH

Statistics

Publications

7

Citations

303

H-Index

7

Active since

2016

Affiliations

University of North Carolina at Chapel Hill(Current)

Sanofi (United States)

University of North Carolina Health Care

Sandra Henein is an author at University of North Carolina at Chapel Hill specializing in infectious diseases, viral vaccines, and vaccinology.

ORCID

Publications per year

2016–2023

7

Publications

7

Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naïve and dengue exposed individuals

Sandra Henein, Jesica Swanstrom, Anthony M. Byers et al. · The Journal of Infectious Diseases · 2016 · 125 citations · Full text

, , +17

Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)

Laura White, Ellen Young, Mark Stoops et al. · PLoS neglected tropical diseases · 2021 · 64 citations · Full text

, , +16

Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection

Sandra Henein, Cameron Adams, Matthew Bonaparte et al. · Journal of Clinical Investigation · 2021 · 46 citations · Full text

, , +13

Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate

Jesica Swanstrom, Sandra Henein, Jessica A. Plante et al. · The Journal of Infectious Diseases · 2018 · 29 citations · Full text

, , +17

A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity

Ellen Young, Boyd L. Yount, Petraleigh Pantoja et al. · Nature Communications · 2023 · 17 citations · Full text

, , +17

1–5 of 7